Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Botensilimab
Rectal Cancer
City of Hope Medical CenterP2B (60)
Botensilimab
Colon Carcinoma
City of Hope Medical CenterP2B (60)
bp102
Cancer
Shandong Suncadia Medicine Co., Ltd.P2B (60)
Brentuximab Vedotin
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow UniversityP2B (60)
Brentuximab Vedotin
Follicular Lymphoma
University of California, DavisP2B (60)
Brentuximab Vedotin
Hematopoietic And Lymphoid System Neoplasm
Yale UniversityP2B (60)
Brentuximab Vedotin
Post-Transplant Lymphoproliferative Disease
Yale UniversityP2B (60)
Busulfanum
Myeloid Leukemia
Dana-Farber Cancer InstituteP2B (60)
Busulfanum
T Lymphoblastic Leukemia/Lymphoma
First Affiliated Hospital of Zhejiang UniversityP2B (60)
bz371a
Erectile Dysfunction
Biozeus Biopharmaceutical S.A.P2B (60)
c105
Her2-Receptor Negative Breast Cancer
University of WashingtonP2B (60)
ca102n
Colorectal Cancer
Holy Stone Healthcare Co., LtdP2B (60)
Cabazitaxel
Hypogonadism
ECOG-ACRIN Cancer Research GroupP2B (60)
Cabazitaxel
Prostate Small Cell Carcinoma
M.D. Anderson Cancer CenterP2B (60)
Cabozantinib
Medullary Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Urinary Bladder Small Cell Neuroendocrine Carcinoma
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Bladder Squamous Cell Carcinoma
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Plasmacytoid Variant Infiltrating Bladder Urothelial Carcinoma
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Kidney Medullary Carcinoma
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Penile Carcinoma
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Melanoma
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Urinary Bladder Cancer
National Cancer Institute (NCI)P2B (60)
Cabozantinib
Penile Cancer
National Cancer Institute (NCI)P2B (60)
Showing 1626 to 1650 of 13,155 assets
PreviousPage 66 of 527Next